メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010-2013

  • Naoko Chiba
  • , Miyuki Morozumi
  • , Michi Shouji
  • , Takeaki Wajima
  • , Satoshi Iwata
  • , Kimiko Ubukata

研究成果: Article › 査読

抄録

We aimed to clarify changes in serotypes and genotypes mediating β-lactam and macrolide resistance in Streptococcus pneumoniae isolates from Japanese children who had invasive pneumococcal disease (IPD) after the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into Japan; 341 participating general hospitals conducted IPD surveillance during April 2010-March 2013. A total of 300 pneumococcal isolates were collected in 2010, 146 in 2011, and 156 in 2012. The proportion of vaccine serotypes in infectious isolates decreased from 73.3% to 54.8% to 14.7% during the 3 years. Among vaccine serotype strains, genotypic penicillin-resistant S. pneumoniae strains also declined each year. Among nonvaccine serotype strains, 19A, 15A, 15B, 15C, and 24 increased in 2012. Increases were noted especially in genotypic penicillin-resistant S. pneumoniae isolates of serotypes 15A and 35B, as well as macrolide resistance mediated by the erm(B) gene in 15A, 15B, 15C, and 24.

本文言語English
ページ(範囲)1132-1139
ページ数8
ジャーナルEmerging Infectious Diseases
巻20
号7
DOI
出版ステータスPublished - 2014 7月
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

  • 疫学
  • 微生物学(医療)
  • 感染症

フィンガープリント

「Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010-2013」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル